Grant or Funding RMPDS recently secured a grant from the National Institute on Drug Abuse to continue research at the Rocky Mountain Poison and Drug Center. This indicates ongoing funded research programs and potential budget lines for contracted research support, data services, and dissemination activities that align with public health and regulatory priorities.

Public Health Focus With a long history in toxicology and services spanning research, education, prevention, and treatment, RMPDS serves public health, government agencies, and pharma/consumer products industries. This breadth signals cross-sector collaboration opportunities for compliance programs, risk assessment, and safety trainings.

Tech Enablement RMPDS utilizes AWS, Smartsheet, and a modern web stack, suggesting readiness for scalable data projects, remote collaboration with clients, and secure information management. Ideal targets include data integration, reporting dashboards, and workflow automation for research and regulatory activities.

Growth Readiness Revenue scale of 25M-50M and a 51-200 employee base indicate mid-market operations with capacity to pilot larger contracts, multi-site studies, or extended service engagements, including training programs, compliance audits, and lifecycle management services for drug safety.

Strategic Partnerships As a Denver Health department with a established reputation and recent NIDA grant, RMPDS is positioned for partnerships around toxicology centers, clinical research services, and government-facing compliance initiatives, offering opportunities for co-development, grant-supported projects, and shared-funded initiatives.